# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 17, "Br J Ophthalmol .", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasJournal> \"Br J Ophthalmol .\"."
1, PublicationYear, 18, 22, "2009", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasPublicationYear> \"2009\"."
2, Title, 109, 225, "A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma .", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasTitle> \"A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma .\"."
3, Randomized, 111, 121, "randomised", "", "<http://ctro/data#ClinicalTrial_106698> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
4, Crossover, 122, 131, "crossover", "", "<http://ctro/data#ClinicalTrial_106698> <http://ctro/data#hasCTDesign> <http://ctro/data#Crossover>."
5, Bimatoprost, 148, 159, "bimatoprost", "", 
6, Latanoprost, 164, 175, "latanoprost", "", 
73, Primary_AngleClosureGlaucoma, 193, 223, "primary angle closure glaucoma", "", "<http://ctro/data#ClinicalTrial_106698> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Primary_AngleClosureGlaucoma>."
7, Author, 226, 232, "How AC", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasAuthor> \"How AC\"."
8, Author, 241, 249, "Kumar RS", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasAuthor> \"Kumar RS\"."
9, Author, 252, 259, "Chen YM", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasAuthor> \"Chen YM\"."
10, Author, 262, 267, "Su DH", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasAuthor> \"Su DH\"."
11, Author, 270, 275, "Gao H", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasAuthor> \"Gao H\"."
12, Author, 278, 284, "Oen FT", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasAuthor> \"Oen FT\"."
13, Author, 287, 292, "Ho CL", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasAuthor> \"Ho CL\"."
14, Author, 295, 302, "Seah SK", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasAuthor> \"Seah SK\"."
15, Author, 305, 311, "Aung T", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasAuthor> \"Aung T\"."
16, Singapore, 373, 382, "Singapore", "", 
107, ObjectiveDescription, 405, 600, "To compare the intraocular pressure ( IOP ) lowering efficacy and side effects of latanoprost 0 . 005 % and bimatoprost 0 . 03 % in subjects with chronic primary angle closure glaucoma ( PACG ) .", "", "<http://ctro/data#ClinicalTrial_106698> <http://ctro/data#hasObjectiveDescription> \"To compare the intraocular pressure ( IOP ) lowering efficacy and side effects of latanoprost 0 . 005 % and bimatoprost 0 . 03 % in subjects with chronic primary angle closure glaucoma ( PACG ) .\"."
18, IOP, 420, 440, "intraocular pressure", "", 
19, IOP, 443, 446, "IOP", "", 
20, Latanoprost, 487, 498, "latanoprost", "", "<http://ctro/data#Latanoprost_106753> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Latanoprost>. <http://ctro/data#Medication_106752> <http://ctro/data#hasDrug> <http://ctro/data#Latanoprost_106753>."
21, DoseValue, 499, 506, "0 . 005", "", "<http://ctro/data#Medication_106752> <http://ctro/data#hasDoseValue> \"0 . 005\"."
22, Percentage, 507, 508, "%", "", "<http://ctro/data#Medication_106752> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
23, Bimatoprost, 513, 524, "bimatoprost", "", "<http://ctro/data#Medication_106759> <http://ctro/data#hasDrug> <http://ctro/data#Bimatoprost>."
77, DoseValue, 525, 531, "0 . 03", "", "<http://ctro/data#Medication_106759> <http://ctro/data#hasDoseValue> \"0 . 03\"."
78, Percentage, 532, 533, "%", "", "<http://ctro/data#Medication_106759> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
78500, Precondition, 537, 598, "subjects with chronic primary angle closure glaucoma ( PACG )", "", "<http://ctro/data#Population_106714> <http://ctro/data#hasPrecondition> \"subjects with chronic primary angle closure glaucoma ( PACG )\"."
75, Primary_AngleClosureGlaucoma, 559, 589, "primary angle closure glaucoma", "", 
76, Primary_AngleClosureGlaucoma, 592, 596, "PACG", "", 
24, Blind, 623, 640, "observer - masked", "", "<http://ctro/data#ClinicalTrial_106698> <http://ctro/data#hasCTDesign> <http://ctro/data#Blind>."
25, Randomized, 641, 651, "randomised", "", 
26, Crossover, 652, 661, "crossover", "", 
27, NumberPatientsCT, 671, 673, "60", "", "<http://ctro/data#ClinicalTrial_106698> <http://ctro/data#hasNumberPatientsCT> \"60\"."
74, Primary_AngleClosureGlaucoma, 674, 678, "PACG", "", 
28, Latanoprost, 708, 719, "latanoprost", "", 
29, Bimatoprost, 723, 734, "bimatoprost", "", 
30, Duration, 739, 746, "6 weeks", "", "<http://ctro/data#ClinicalTrial_106698> <http://ctro/data#hasCTduration> \"6 weeks\"."
32, Crossover, 771, 783, "crossed over", "", 
31, Duration, 820, 827, "6 weeks", "", 
33, IOP, 834, 837, "IOP", "", 
34, IOP, 908, 911, "IOP", "", 
78505, TimePoint, 918, 925, "6 weeks", "", 
78504, TimePoint, 953, 961, "baseline", "", 
36, FinalNumPatientsCT, 974, 986, "Fifty - four", "", "<http://ctro/data#ClinicalTrial_106698> <http://ctro/data#hasFinalNumberPatientsCT> \"Fifty - four\"."
37, Latanoprost, 1030, 1041, "Latanoprost", "", 
38, IOP, 1050, 1053, "IOP", "", "<http://ctro/data#IOP_106780> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IOP>. <http://ctro/data#Endpoint_106779> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IOP_106780>."
121, Mean, 1056, 1060, "mean", "", "<http://ctro/data#Mean_106781> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_106779> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_106781>."
39, Reduction, 1073, 1078, "8 . 4", "", "<http://ctro/data#Outcome_106784> <http://ctro/data#hasChangeValue> \"8 . 4\"."
40, SdDevChangeValue, 1081, 1086, "3 . 8", "", "<http://ctro/data#Outcome_106784> <http://ctro/data#hasSdDevChangeValue> \"3 . 8\"."
41, mmHg, 1089, 1094, "mm Hg", "", "<http://ctro/data#Endpoint_106779> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
42, Bimatoprost, 1099, 1110, "bimatoprost", "", 
43, Reduction, 1114, 1119, "8 . 9", "", "<http://ctro/data#Outcome_106811> <http://ctro/data#hasChangeValue> \"8 . 9\"."
44, SdDevChangeValue, 1122, 1127, "3 . 9", "", "<http://ctro/data#Outcome_106811> <http://ctro/data#hasSdDevChangeValue> \"3 . 9\"."
45, mmHg, 1130, 1135, "mm Hg", "", 
78506, TimePoint, 1143, 1151, "baseline", "", 
46, BaseLineValue, 1155, 1161, "25 . 2", "", "<http://ctro/data#Outcome_106784> <http://ctro/data#hasBaselineValue> \"25 . 2\"."
47, SdDevBL, 1164, 1169, "3 . 6", "", "<http://ctro/data#Outcome_106784> <http://ctro/data#hasSdDevBL> \"3 . 6\"."
48, mmHg, 1172, 1177, "mm Hg", "", 
49, BaseLineValue, 1182, 1188, "25 . 2", "", "<http://ctro/data#Outcome_106811> <http://ctro/data#hasBaselineValue> \"25 . 2\"."
50, SdDevBL, 1191, 1196, "3 . 6", "", "<http://ctro/data#Outcome_106811> <http://ctro/data#hasSdDevBL> \"3 . 6\"."
51, mmHg, 1199, 1204, "mm Hg", "", 
135, PvalueDiff, 1222, 1230, "= 0 . 23", "", "<http://ctro/data#DiffBetweenGroups_106838> <http://ctro/data#hasPvalueDiff> \"= 0 . 23\"."
78507, EndPointDescription, 1324, 1337, "adverse event", "", "<http://ctro/data#EndPointDescription_106848> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_106847> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_106848>."
53, Bimatoprost, 1345, 1356, "bimatoprost", "", 
54, PercentageAffected, 1365, 1367, "81", "", "<http://ctro/data#Outcome_106879> <http://ctro/data#hasPercentageAffected> \"81\"."
55, Latanoprost, 1390, 1401, "latanoprost", "", 
56, PercentageAffected, 1410, 1412, "40", "", "<http://ctro/data#Outcome_106852> <http://ctro/data#hasPercentageAffected> \"40\"."
141, PvalueDiff, 1419, 1427, "< 0 . 01", "", "<http://ctro/data#DiffBetweenGroups_106906> <http://ctro/data#hasPvalueDiff> \"< 0 . 01\"."
78510, EndPointDescription, 1432, 1449, "Ocular irritation", "", 
58, NumberAffected, 1514, 1516, "22", "", "<http://ctro/data#Outcome_106947> <http://ctro/data#hasNumberAffected> \"22\"."
59, PercentageAffected, 1528, 1534, "37 . 9", "", "<http://ctro/data#Outcome_106947> <http://ctro/data#hasPercentageAffected> \"37 . 9\"."
60, Bimatoprost, 1552, 1563, "bimatoprost", "", 
146, OcularHypertension, 1576, 1593, "ocular hyperaemia", "", "<http://ctro/data#ClinicalTrial_106698> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
61, NumberAffected, 1611, 1613, "13", "", "<http://ctro/data#Outcome_106920> <http://ctro/data#hasNumberAffected> \"13\"."
62, PercentageAffected, 1625, 1631, "22 . 4", "", "<http://ctro/data#Outcome_106920> <http://ctro/data#hasPercentageAffected> \"22 . 4\"."
63, Latanoprost, 1649, 1660, "latanoprost", "", 
150, PvalueDiff, 1665, 1673, "= 0 . 11", "", "<http://ctro/data#DiffBetweenGroups_106975> <http://ctro/data#hasPvalueDiff> \"= 0 . 11\"."
67, Bimatoprost, 1692, 1703, "Bimatoprost", "", 
65, ConclusionComment, 1692, 1823, "Bimatoprost once daily was similarly effective in reducing IOP compared with latanoprost once daily in subjects with chronic PACG .", "", "<http://ctro/data#ClinicalTrial_106698> <http://ctro/data#hasConclusionComment> \"Bimatoprost once daily was similarly effective in reducing IOP compared with latanoprost once daily in subjects with chronic PACG .\"."
68, Frequency, 1704, 1714, "once daily", "", "<http://ctro/data#Intervention_106746> <http://ctro/data#hasFrequency> \"once daily\"."
69, IOP, 1751, 1754, "IOP", "", 
70, Latanoprost, 1769, 1780, "latanoprost", "", 
71, Frequency, 1781, 1791, "once daily", "", "<http://ctro/data#Intervention_106740> <http://ctro/data#hasFrequency> \"once daily\"."
156, Primary_AngleClosureGlaucoma, 1817, 1821, "PACG", "", 
66, ConclusionComment, 1824, 1888, "Both drugs were well tolerated with mild ocular adverse events .", "", "<http://ctro/data#ClinicalTrial_106698> <http://ctro/data#hasConclusionComment> \"Both drugs were well tolerated with mild ocular adverse events .\"."
72, PMID, 1934, 1942, "19336424", "", "<http://ctro/data#Publication_106691> <http://ctro/data#hasPMID> \"19336424\"."
